These results, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 aid the strategy of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Issues. Can help to scale back https://carlp591ecq0.wikijournalist.com/user